Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)

NCT02062385 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4040

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Gastroenteritis

Interventions

BIOLOGICAL: V260
BIOLOGICAL: Placebo to V260
BIOLOGICAL: OPV
BIOLOGICAL: DTaP

Sponsor

Merck Sharp & Dohme LLC